Axogen, Inc. Interest Expense Nonoperating
Axogen, Inc. (AXGN) reported Interest Expense Nonoperating of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-29
- Axogen, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $1.00K, a 99.95% decline year-over-year.
- Axogen, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $694.00K, a 69.16% decline year-over-year.
- Axogen, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $1.72M, a 4.61% decline year-over-year.
- Axogen, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $1.76M, a 7.18% decline year-over-year.
- Axogen, Inc. interest expense nonoperating for fiscal 2025 was $7.70M, a 6.14% decline from fiscal 2024.
- Axogen, Inc. interest expense nonoperating for fiscal 2024 was $8.21M, a 189.45% increase from fiscal 2023.
- Axogen, Inc. interest expense nonoperating for fiscal 2023 was $2.83M, a 354.33% increase from fiscal 2022.
- Axogen, Inc. interest expense nonoperating for fiscal 2022 was $624.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-07-29 | $695.00K 10-Q · filed 2026-07-29 | $2.41M derived: sum of 3 quarters · filed 2026-07-29 | $4.17M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $694.00K 10-Q · filed 2026-04-28 | $2.41M derived: sum of 2 quarters · filed 2026-04-28 | $4.17M derived: sum of 3 quarters · filed 2026-04-28 | $6.15M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.48M derived: sum of 2 quarters · filed 2026-02-24 | $5.45M derived: sum of 3 quarters · filed 2026-07-29 | $7.70M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.76M 10-Q · filed 2025-10-29 | $3.73M derived: sum of 2 quarters · filed 2026-07-29 | $5.98M 10-Q · filed 2025-10-29 | $7.79M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.98M 10-Q · filed 2026-07-29 | $4.23M 10-Q · filed 2026-07-29 | $6.03M derived: sum of 3 quarters · filed 2026-07-29 | $7.92M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.25M 10-Q · filed 2026-04-28 | $4.05M derived: sum of 2 quarters · filed 2026-04-28 | $5.94M derived: sum of 3 quarters · filed 2026-04-28 | $8.13M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.69M derived: sum of 2 quarters · filed 2026-02-24 | $5.88M derived: sum of 3 quarters · filed 2026-02-24 | $8.21M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.89M 10-Q · filed 2025-10-29 | $4.08M derived: sum of 2 quarters · filed 2025-10-29 | $6.41M 10-Q · filed 2025-10-29 | $8.25M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.19M 10-Q · filed 2025-08-05 | $4.51M 10-Q · filed 2025-08-05 | $6.35M derived: sum of 3 quarters · filed 2026-02-24 | $7.18M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $2.33M 10-Q · filed 2025-05-08 | $4.17M derived: sum of 2 quarters · filed 2026-02-24 | $5.00M derived: sum of 3 quarters · filed 2026-02-24 | $5.14M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.67M derived: sum of 2 quarters · filed 2026-02-24 | $2.82M derived: sum of 3 quarters · filed 2026-02-24 | $2.83M 10-K · filed 2026-02-24 |
| 2023-09-30 | $827.00K 10-Q · filed 2024-11-07 | $975.00K derived: sum of 2 quarters · filed 2024-11-07 | $992.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $148.00K 10-Q · filed 2024-08-08 | $164.00K 10-Q · filed 2024-08-08 | ||
| 2022-12-31 | $624.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |